Renal genetic disorders related to K+ and Mg2+

Annual Review of Physiology

Volumn 64, Issue , 2002, Pages 845-876

  Warnock, David G ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Bartter's syndrome; Epithelia transport; Epithelial sodium channel; Gitelman's syndrome; Liddle's syndrome

Indexed keywords

CARRIER PROTEIN; CELL MEMBRANE PROTEIN; MAGNESIUM ION; POTASSIUM ION; SODIUM CHANNEL;

BARTTER SYNDROME; CELL MEMBRANE TRANSPORT; CLINICAL FEATURE; ELECTROLYTE BALANCE; GITELMAN SYNDROME; HUMAN; KIDNEY EPITHELIUM; LIDDLE SYNDROME; MOLECULAR DYNAMICS; NOMENCLATURE; NONHUMAN; PATHOPHYSIOLOGY; POTASSIUM TRANSPORT; PRIORITY JOURNAL; REVIEW; SYNDROME DELINEATION; TRANSPORT KINETICS;

HUMANS; KIDNEY DISEASES; MAGNESIUM; POTASSIUM;

EID: 0036200333     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.64.081501.160000     Document Type: Review

References (189)

1. Genetic disorders of renal electrolyte transport
2. Potassium transport: From clearance to channels and pumps
3. Renal potassium transport: Mechanisms and regulation
4. Potassium secretion and the regulation of distal nephron K channels
5. Cum grano salis - The epithelial sodium channel and the control of blood pressure
6. Differential regulation of ROMK expression in kidney cortex and medulla by aldosterone and potassium
7. Aldosterone and potassium secretion by the cortical collecting duct
8. Phosphatidylinositol 4,5-bisphosphate and intracellular pH regulate the ROMK1 potassium channel via separate but interrelated mechanisms
9. Regulation of ROMK1 channel by protein kinase A via a phosphatidylinositol 4,5-bisphosphate-dependent mechanism
10. Molecular mechanisms of human hypertension
11. Genetic renal tubular disorders of renal ion channels and transporters
12. Defective regulation of the epithelial Na-channel by Nedd4 in Liddle's syndrome
13. Involvement of renal apical Na transport systems in the control of blood pressure
14. Genetic analysis of the epithelial sodium channel in Liddle's syndrome
15. Two sporadic cases of Liddle's syndrome caused by de novo ENaC mutations
16. + channel in Liddle's syndrome and autosomal recessive pseudohypoaldosteronism, type 1
17. Liddle's syndrome: A 14-year follow-up of the youngest diagnosed case
18. Liddle's syndrome: A report in a middle-aged woman
19. Liddle's syndrome in an elderly woman
20. Genetic forms of human hypertension
21. The epithelial sodium channel in hypertension
22. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion
23. Brief report: Liddle's syndrome revisited - A disorder of sodium reabsorption in the distal tubule
24. Regulation of aldosterone secretion in hypertensive blacks
25. Liddle's syndrome: Prospective genetic screening and suppressed aldosterone secretion in an extended kindred
26. Liddle syndrome: An autosomal dominant form of human hypertension
27. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
28. A chimaeric 11 β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
29. Molecular genetics of human blood pressure variation
30. Glucocorticoid-remediable aldosteronism and pregnancy
31. Biochemical evidence of aldosterone over-production and abnormal regulation in normotensive individuals with familial hyperaldosteronism type I
32. Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertension
33. Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbance
34. In familial hyperaldosteronism type I, hybrid gene-induced aldosterone production dominates that induced by wild-type genes
35. Primary aldosteronism: Learning from the study of familial varieties
36. Familial hyperaldosteronism type II: Description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene
37. Linkage analysis of familial hyperaldosteronism type II-absence of linkage to the gene encoding the angiotensin II receptor type I
38. A novel genetic locus for low renin hypertension: Familial hyperaldosteronism type II maps to chromosome 7 (7p22)
39. Sodium status, corticosteroid metabolism and blood pressure in normal human subjects and in a patient with abnormal salt appetite
40. Low renin hypertension in the next millennium
41. Molecular basis of human salt sensitivity: The role of the 11beta-hydroxysteroid dehydrogenase type 2
42. Role of 11 beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation
43. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: A new syndrome
44. Bartter syndrome: Unraveling the pathophysiologic enigma
45. Antenatal Bartter syndrome with sensorineural deafness: Refinement of the locus on chromosome 1p31
46. Linkage of infantile Bartter syndrome with sensorineural deafness to chromosome 1p
47. Bartter syndrome revisited
48. Mutations in the gene encoding the inwardly-rectifiying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: Evidence for genetic heterogeneity
49. Two novel mutations of the gene for Kir 1.1 (ROMK) in neonatal Bartter syndrome
50. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
51. + channel, ROMK
52. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2
53. Association of pseudo-Bartter syndrome and autosomal dominant hypocalcemia due to a mutation in the calcium-sensing receptor gene
54. Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family
55. Functional interaction of the K-Cl cotransporter (KCCl) with the Na-K-Cl cotransporter in HEK-293 cells
56. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome
57. Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome
58. Phenotypic variability in Bartter syndrome type I
59. Uncompensated polyuria in a mouse model of Bartter's syndrome
60. Large deletion of the 5′ end of the ROMK1 gene causes antenatal Bartter syndrome
61. Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome
62. Stable, polarised, functional expression of Kir1.1b channel protein in Madin-Darby canine kidney cell line
63. pH gating of ROMK (K(ir)1.1) channels: Control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome
64. Functional consequences of ROMK mutants linked to antenatal Bartter's syndrome and implications for treatment
65. A mutation linked with Bartter's syndrome locks Kir 1.la (ROMK1) channels in a closed state
66. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype
67. Molecular pathology of renal chloride channels in Dent's disease and Bartter's syndrome
68. Ion transport mechanisms in thick ascending limb of Henle's loop of mammalian nephron
69. Divalent cation transport by the distal nephron: Insights from Bartter's and Gitelman's syndromes
70. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity
71. Adrenomedullin and nitrite levels in children with Bartter syndrome
72. Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome
73. A case of living-related kidney transplantation in Bartter's syndrome
74. A new familial disorder characterized by hypokalemia and hypomagnesemia
75. Bartter's syndrome: Evidence suggesting a distal tubular defect in a hypocalciuric variant of the syndrome
76. Possible discrimination of Gitelman's syndrome from Bartter's syndrome by renal clearance study: Report of two cases
77. - by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman's syndrome
78. Peripheral blood mononuclear cells express mutated NCCT mRNA in Gitelman's syndrome: Evidence for abnormal thiazide-sensitive NaCl cotransport
79. - cotransporter of the distal convoluted tubule
80. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter
81. Linkage of Gitelman syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families
82. Gitelman's syndrome (Bartter's variant) maps to the thiazide-sensitive cotransporter gene locus on chromosome 16q13 in a large kindred
83. Gitelman's syndrome is genetically distinct from other forms of Bartter's syndrome
84. Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain
85. Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman's syndrome
86. Novel molecular variants of the NaCl cotransporter gene are responsible for Gitelman syndrome
87. Novel mutations in thiazide-sensitive Na-Cl cotransporter gene of patients with Gitelman's syndrome
88. Genetic variants of thiazide-sensitive NaCl-cotransporter in Gitelman's syndrome and primary hypertension
89. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes
90. Genetic heterogeneity in tubular hypomagnesemia-hypokalemia with hypocalciuria (Gitelman's syndrome)
91. Recombinant human growth hormone and Gitelman's syndrome
92. Gitelman disease associated with growth hormone deficiency, disturbances in vasopressin secretion and empty sella: A new hereditary renal tubular-pituitary syndrome?
93. Sclerochoroidal calcification associated with Gitelman syndrome
94. A case of Gitelman's syndrome with chondrocalcinosis
95. Chondro-calcinosis is a feature of Gitelman's variant of Bartter's syndrome. A new look at the hypomagnesemia associated with calcium pyrophosphate dihydrate crystal deposition disease
96. Choroidal calcifications in patients with Gitelman's syndrome
97. Gitelman's syndrome revisited: An evaluation of symptoms and health-related quality of life
98. Outcome of two pregnancies in a patient with Gitelman's syndrome - A case report
99. 2+ channel ECaC
100. Gene structure and chromosomal mapping of human epithelial calcium channel
101. 2+ channel (ECaCl)
102. The epithelial calcium channel, ECaC, is activated by hyperpolarization and regulated by cytosolic calcium
103. CaTl manifests the pore properties of the calcium-release-activated calcium channel
104. A rat kidney-specific calcium transporter in the distal nephron
105. Renal tubular function in children and adolescents with Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome
106. Evidence for disturbed regulation of calciotropic hormone metabolism in Gitelman syndrome
107. Magnesium supplementation in Gitelman syndrome
108. Distal nephron function in familial hypokalemia-hypomagnesemia (Gitelman's syndrome)
109. Pseudohypoaldosteronism: Multiple target organ unresponsiveness to mineralocorticoid hormones
110. Pseudohypoaldosteronism. Clinical, biochemical and morphological studies in a long-term follow-up
111. Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis
112. A patient with pseudohypoaldosteronism type 1 and respiratory distress syndrome
113. Recurrent pseudomonas bronchopneumonia and other symptoms as in cystic fibrosis in a child with type I pseudohypoaldosteronism
114. Lung symptoms in pseudohypoaldosteronism type 1 are associated with deficiency of the alpha-subunit of the epithelial sodium channel
115. Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism
116. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1
117. A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families
118. Early death due to defective neonatal lung liquid clearance in αENaC-deficient mice
119. A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism
120. + channel in mice: Hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype
121. Potassium metabolism in extremely low birth weight infants in the first week of life
122. Effect of prenatal steroids on potassium balance in extremely low birth weight neonates
123. Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta-subunit of the amiloride-sensitive epithelial sodium channel
124. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects
125. A partial form of pseudohypoaldosteronism type I without renal sodium wasting
126. Early childhood hyperkalemia: Variety of pseudohypoaldosteronism
127. Pseudohypoaldosteronism: Molecular characterization of the mineralocorticoid receptor
128. Familial pseudohypoaldosteronism: A review on the heterogeneity of the syndrome
129. Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism
130. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism
131. Evidence for genetic heterogeneity of pseudohypoaldosteronism Type 1: Identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds
132. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1
133. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism, type I
134. Nephrocalcinosis in pseudohypoaldosteronism and the effect of indomethacin therapy
135. Effect of hydrochlorothiazide in pseudohypoaldosteronism with hypercalciuria and severe hyperkalemia
136. Familial pseudohypoaldosteronism
137. Hypertension and hyperpotassemia without renal disease in a young male
138. Hyperkalemia, hypertension and systemic acidosis without renal failure associated with a tubular defect in potassium excretion
139. Hyperkalemia, acidosis, and short stature associated with a defect in renal potassium excretion
140. Short stature, hyperkalemia and acidosis: A defect in renal transport of potassium
141. Familial hyperkalemia, hypertension, and hyporeninemia with normal aldosterone levels. A tubular defect in potassium handling
142. Proximal renal tubular acidosis: Association with familial normaldosteronemic hyperpotassemia and hypertension
143. Pseudohypoaldosteronism type II: Proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia
144. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction
145. The syndrome of hypertension and hyperkalemia with normal glomerular filtration rate: Gordon's syndrome
146. The syndrome of hypertension and hyperkalaemia without renal failure: Long term correction by thiazide diuretic
147. The syndrome of hypertension and hyperkalaemia with normal GFR. A unique pathophysiological mechanism for hypertension?
148. Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: Possible hereditary cell membrane defect
149. Endocrine sodium and volume regulation in familial hyperkalemia with hypertension
150. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): Role of increased renal chloride reabsorption
151. Increased chloride reabsorption as an inherited renal tubular defect in familial type II pseudohypoaldosteronism
152. Pseudohypoaldosteronism: Case report and discussion of the syndrome
153. A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension
154. Hypertension familiale hyperkaliemique: Analyse de la variabilité phenotypique par l'étude de 7 families
155. The syndrome of hypertension and hyperkalaemia with normal glomerular function (Gordon's syndrome). A pathophysiological study
156. Hyperkalemic periodic paralysis in Gordon's syndrome: A possible defect in atrial natriuretic peptide function
157. Treatment of mineralocorticoid-resistant renal hyperkalemia with hypertension (type II pseudohypoaldosteronism)
158. Paracellular solute transport: More than just a leak?
159. 2+ resorption
160. Vasopressin-stimulated chloride transport in trans-immortalized mouse cell lines derived from the distal convoluted tubule and cortical and inner medullary collecting ducts
161. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes lq31-42 and 17p11-q21
162. Linkage of Gordon's syndrome to the long arm of chromosome 17 in a region recently linked to familial essential hypertension
163. Gordon's syndrome, renal tubule, chromosome 17 and essential hypertension: A credible link?
164. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study
165. Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II
166. Pseudohypoaldosteronism with normal blood pressure
167. Mineralocorticoid-induced kaliuresis in type-II pseudohypoaldosteronism
168. Liddle's syndrome: Heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel
169. Inherited disorders of renal magnesium handling
170. Extracellular calcium sensing and extracellular calcium signaling
171. Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium
172. Calcium pyrophosphate dihydrate deposition disease and familial hypomagnesemia
173. Renal magnesium wasting, incomplete tubular acidosis, hypercalciuria and nephrocalcinosis in siblings
174. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis
175. Familial hypomagnesaemia - Hypercalciuria leading to end-stage renal failure
176. Hypomagnesaemia-hypercalciuria-nephrocalcinosis: A report of nine cases and a review
177. Renal magnesium wasting in two families with autosomal dominant inheritance
178. +-ATPase gamma-subunit
179. Isolated autosomal recessive renal magnesium loss in two sisters
180. Primary hypomagnesemia with secondary hypocalcemia in an infant
181. Clinical presentation and outcome in primary familial hypomagnesaemia
182. Primary infantile hypomagnesaemia; report of two cases and review of literature
183. Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: Genetic linkage mapping and analysis of a balanced translocation breakpoint
184. Epithelial magnesium transport and regulation by the kidney
185. Renal magnesium handling: New insights in understanding old problems
186. Magnesium transport in the renal distal convoluted tubule
187. 2+ uptake in mouse distal convoluted tubule cells
188. 2+
189. 2+ channel